Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus gliclazide crossover study of vascular function and adipose AMPK activation in type 2 diabetes
ISRCTN51336867Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Mar 2004
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of metformin and gliclazide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoints: Body mass index, Blood pressure and 5 more. Started Mar 2004; status: completed.
02
Drugs
metformingliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN51336867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51336867.